Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell wall and thiol-containing bacterial proteins represent a collective group of targets for broad-spectrum antiseptic and disinfectant agents. The bacterial cell wall is a complex structure essential for maintaining osmotic pressure and structural integrity, while thiol-containing proteins, such as various metabolic enzymes and thioredoxins, are critical for cellular catalysis and maintaining the redox environment (PubMed, PMID: 16126236). Antimicrobial agents like organomercurials (e.g., thimerosal) and silver ions target these components by reacting with the sulfhydryl (-SH) groups of cysteine residues, which results in the widespread inactivation of essential bacterial pathways (StatPearls, 2023). This multi-target mechanism of action provides a broad range of activity against both Gram-positive and Gram-negative bacteria. However, due to the non-specific nature of these interactions and the potential for toxicity in human tissues, these targets are primarily utilized for topical antisepsis or as preservatives in biological products rather than for systemic antibiotic therapy (NIH, PubChem). This entry is considered a composite target rather than a single molecular entity, reflecting a general pharmacological mechanism rather than a specific receptor interaction.
These agents exert antimicrobial activity by covalently binding to sulfhydryl (thiol) groups on bacterial enzymes and structural proteins, forming mercaptides that lead to protein denaturation and enzymatic inactivation (StatPearls, 2023; PubChem, CID 71308). Additionally, they can non-specifically disrupt the bacterial cell wall and plasma membrane, leading to increased permeability and cell death.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall and thiol-containing bacterial proteins.